Abstract

The real origin of fibroblast during the development of renal fibrosis is still uncertain. In a recent paper by Asada and colleagues the Authors demonstrated that the majority of Erythropoietin-producing fibroblasts in the healthy kidney originate from myelin-positive extra renal cells. During the development of renal fibrosis, these extrarenal fibroblast trans-differentiated into myofibroblasts with concomitant loss of erythropoietin production. These intriguing data might lead to the development of new drugs both capable to reduce renal fibrosis and preserve the production of endogenous Erythropoietin.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.